134 related articles for article (PubMed ID: 38102738)
21. Redox-dependent AMPK inactivation disrupts metabolic adaptation to glucose starvation in xCT-overexpressing cancer cells.
Lee Y; Itahana Y; Ong CC; Itahana K
J Cell Sci; 2022 Aug; 135(15):. PubMed ID: 35775474
[TBL] [Abstract][Full Text] [Related]
22. Disulfidptosis: disulfide stress-induced cell death.
Liu X; Zhuang L; Gan B
Trends Cell Biol; 2024 Apr; 34(4):327-337. PubMed ID: 37574347
[TBL] [Abstract][Full Text] [Related]
23. Analysis of the effects of polyunsaturated fatty acids on transporter expressions using a PCR array: Induction of xCT/SLC7A11 in human placental BeWo cells.
Ono K; Furugen A; Kurosawa Y; Jinno N; Narumi K; Kobayashi M; Iseki K
Placenta; 2019 Jan; 75():34-41. PubMed ID: 30712664
[TBL] [Abstract][Full Text] [Related]
24. ATF4 suppresses hepatocarcinogenesis by inducing SLC7A11 (xCT) to block stress-related ferroptosis.
He F; Zhang P; Liu J; Wang R; Kaufman RJ; Yaden BC; Karin M
J Hepatol; 2023 Aug; 79(2):362-377. PubMed ID: 36996941
[TBL] [Abstract][Full Text] [Related]
25. SLC7A11 Overexpression in Glioblastoma Is Associated with Increased Cancer Stem Cell-Like Properties.
Polewski MD; Reveron-Thornton RF; Cherryholmes GA; Marinov GK; Aboody KS
Stem Cells Dev; 2017 Sep; 26(17):1236-1246. PubMed ID: 28610554
[TBL] [Abstract][Full Text] [Related]
26. Glial Glutamate Transporter-Mediated Plasticity: System x
Dahlmanns M; Dahlmanns JK; Savaskan N; Steiner HH; Yakubov E
Front Biosci (Landmark Ed); 2023 Mar; 28(3):57. PubMed ID: 37005761
[TBL] [Abstract][Full Text] [Related]
27. Oncogenic PI3K promotes methionine dependency in breast cancer cells through the cystine-glutamate antiporter xCT.
Lien EC; Ghisolfi L; Geck RC; Asara JM; Toker A
Sci Signal; 2017 Dec; 10(510):. PubMed ID: 29259101
[TBL] [Abstract][Full Text] [Related]
28. Biological insights in non-small cell lung cancer.
Rosell R; Jain A; Codony-Servat J; Jantus-Lewintre E; Morrison B; Ginesta JB; González-Cao M
Cancer Biol Med; 2023 Jun; 20(7):500-18. PubMed ID: 37381723
[TBL] [Abstract][Full Text] [Related]
29. The Role of Cystine/Glutamate Antiporter SLC7A11/xCT in the Pathophysiology of Cancer.
Jyotsana N; Ta KT; DelGiorno KE
Front Oncol; 2022; 12():858462. PubMed ID: 35280777
[TBL] [Abstract][Full Text] [Related]
30. The solute carrier family 7 member 11 (SLC7A11) is regulated by LH/androgen and required for cystine/glutathione homeostasis in mouse Sertoli cells.
Liu Z; Wang H; Larsen M; Gunewardana S; Cendali FI; Reisz JA; Akiyama H; Behringer RR; Ma Q; Hammoud SS; Kumar TR
Mol Cell Endocrinol; 2022 Jun; 549():111641. PubMed ID: 35398053
[TBL] [Abstract][Full Text] [Related]
31. Transcriptional control of cystine/glutamate transporter gene by amino acid deprivation.
Sato H; Nomura S; Maebara K; Sato K; Tamba M; Bannai S
Biochem Biophys Res Commun; 2004 Dec; 325(1):109-16. PubMed ID: 15522208
[TBL] [Abstract][Full Text] [Related]
32. Up-regulation of SLC7A11/xCT creates a vulnerability to selenocystine-induced cytotoxicity.
Tan SLW; Tan HM; Israeli E; Fatihah I; Ramachandran V; Ali SB; Goh SJA; Wee J; Tan AQL; Tam WL; Han W
Biochem J; 2023 Dec; 480(24):2045-2058. PubMed ID: 38078799
[TBL] [Abstract][Full Text] [Related]
33. Cystine-glutamate antiporter xCT as a therapeutic target for cancer.
Liu L; Liu R; Liu Y; Li G; Chen Q; Liu X; Ma S
Cell Biochem Funct; 2021 Mar; 39(2):174-179. PubMed ID: 32749001
[TBL] [Abstract][Full Text] [Related]
34. Targeting SIRT3 sensitizes glioblastoma to ferroptosis by promoting mitophagy and inhibiting SLC7A11.
Li X; Zhang W; Xing Z; Hu S; Zhang G; Wang T; Wang T; Fan Q; Chen G; Cheng J; Jiang X; Cai R
Cell Death Dis; 2024 Feb; 15(2):168. PubMed ID: 38395990
[TBL] [Abstract][Full Text] [Related]
35. SLC7A11/ xCT is a target of miR-5096 and its restoration partially rescues miR-5096-mediated ferroptosis and anti-tumor effects in human breast cancer cells.
Yadav P; Sharma P; Sundaram S; Venkatraman G; Bera AK; Karunagaran D
Cancer Lett; 2021 Dec; 522():211-224. PubMed ID: 34571083
[TBL] [Abstract][Full Text] [Related]
36. Actin cytoskeleton vulnerability to disulfide stress mediates disulfidptosis.
Liu X; Nie L; Zhang Y; Yan Y; Wang C; Colic M; Olszewski K; Horbath A; Chen X; Lei G; Mao C; Wu S; Zhuang L; Poyurovsky MV; James You M; Hart T; Billadeau DD; Chen J; Gan B
Nat Cell Biol; 2023 Mar; 25(3):404-414. PubMed ID: 36747082
[TBL] [Abstract][Full Text] [Related]
37. Age-dependent oxidation of extracellular cysteine/cystine redox state (E
Zheng Y; Ritzenthaler JD; Burke TJ; Otero J; Roman J; Watson WH
Free Radic Biol Med; 2018 Apr; 118():13-22. PubMed ID: 29458149
[TBL] [Abstract][Full Text] [Related]
38. Role of SLC7A11/xCT in Ovarian Cancer.
Fantone S; Piani F; Olivieri F; Rippo MR; Sirico A; Di Simone N; Marzioni D; Tossetta G
Int J Mol Sci; 2024 Jan; 25(1):. PubMed ID: 38203758
[TBL] [Abstract][Full Text] [Related]
39. SLC7A11, a component of cysteine/glutamate transporter, is a novel biomarker for the diagnosis and prognosis in laryngeal squamous cell carcinoma.
Ma Z; Zhang H; Lian M; Yue C; Dong G; Jin Y; Li R; Wan H; Wang R; Wang Y; Zhai J; Ma H; Feng L; Han J; Liu S; Guo Y; Li J; Liu Y; Fang J; Liu H
Oncol Rep; 2017 Nov; 38(5):3019-3029. PubMed ID: 29048627
[TBL] [Abstract][Full Text] [Related]
40. High expression of cystine-glutamate antiporter xCT (SLC7A11) is an independent biomarker for epileptic seizures at diagnosis in glioma.
Sørensen MF; Heimisdóttir SB; Sørensen MD; Mellegaard CS; Wohlleben H; Kristensen BW; Beier CP
J Neurooncol; 2018 May; 138(1):49-53. PubMed ID: 29404978
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
